Medtronic Cardiac Ablation Solutions

This study follows 200 people with a type of irregular heartbeat (paroxysmal atrial fibrillation) who are treated with a special freezing catheter. The goal is to see how well the procedure prevents the heart rhythm problem from coming back over 3 years, and to check for any safe…

This study tests a new device called the Sphere-9 catheter and Affera ablation system to treat ventricular tachycardia (VT), a fast heart rhythm that can be life-threatening. About 60 adults with VT caused by heart scarring will receive this procedure. The goal is to safely stop …

This study follows 580 adults with atrial fibrillation who are treated with the PulseSelect PFA system, a device that uses electrical pulses to fix irregular heartbeats. Researchers will monitor participants for 36 months to see how well the procedure prevents heart rhythm proble…

This study follows up to 1,950 people with atrial fibrillation who are treated with the PulseSelect PFA system, a device that uses electrical pulses to correct irregular heartbeats. Researchers will track how well the procedure prevents abnormal heart rhythms and whether any seri…

This study tests a new device, the SpherePVI catheter, to treat a heart rhythm problem called atrial fibrillation (AFib). About 100 adults with AFib will receive this treatment to see if it safely and effectively restores normal heart rhythm by isolating the veins that trigger th…

This study is for people whose atrial fibrillation (an irregular heartbeat) has come back after a first ablation procedure. It will test a new catheter system (Sphere-9 and Affera) designed to safely and effectively treat the condition again. Up to 400 participants will receive t…

This study tests a new catheter and mapping system designed to treat paroxysmal atrial fibrillation (AFib), a condition where the heart beats irregularly. About 300 adults with symptomatic AFib will undergo a procedure to destroy small areas of heart tissue causing the problem. T…

This study tests a new system that uses heat to create small scars in the heart to block faulty electrical signals causing atrial fibrillation (an irregular heartbeat). About 150 adults with this condition will receive the procedure. The goal is to see if it safely and effectivel…

This study is a global registry that will follow about 540 people with atrial fibrillation who are treated with the Affera ablation platform. The goal is to see how well the device works and how safe it is in everyday medical practice. Participants will be observed over time to c…